Tag: GLP-1
More than 1 in 10 US adults now take weight-loss drugs
The new numbers mark the clearest sign yet that a wave of injectable medicines is reshaping American waistlines.
The food thoughts that won’t quiet down: Who hears them most, by age and sex
If food is always on your mind between meals, researchers are starting to figure out why some people can't shake that chatter.
New analysis: People with lower BMI may also benefit from GLP-1 drugs
A analysis argues that roughly half of adults just above a healthy weight already carry hidden heart-risk.
A once-a-month weight loss injection could replace weekly jabs, new data shows
A trial showed monthly GLP-1 dosing kept working after switching from weekly shots.
Millions may lose GLP-1 drug coverage as employers and insurers cut benefits
The bill for weight-loss drugs like Wegovy is landing on patients as major insurers pull back.
Nearly 1 in 6 children on weight loss drugs developed a nutritional deficiency within a year
A new US study of more than 2,000 children on GLP-1 medications found that 16.8 percent developed a nutritional deficiency within twelve months, and vitamin D led the list.